Site Search
Professionals 612 results
Capabilities 80 results
Industry
Practice Area
Our nationally recognized Appellate & Critical Motions (ACM) Practice delivers sophisticated legal advocacy and analysis before trial, at trial, and on appeal. From state trial courts to the U.S. Supreme Court, our ACM attorneys identify, preserve, and present the critical legal issues that can make the difference between winning and losing.
Practice Area
Our capital markets and securities attorneys represent U.S. and international issuers, institutional investors, underwriters, and placement agents in a wide variety of public and private offerings of debt and equity securities.
Experience 413 results
Experience
|May 7, 2024
Experience
|April 29, 2024
Winston advised the partners of BCF Life Sciences Group in its sale to Sparkfood
Experience
|April 10, 2024
Winston assists Eurazeo in the financing of Vulcain Ingénierie's fourth LBO
Insights & News 7,146 results
Speaking Engagement
|June 20, 2024
Winston & Strawn partner Kurt Mathas will speak at the 15thSummit on Biosimilars & Innovator Biologics, June 20-21, 2024, in New York. The summit—which attracts the “who’s who” of the industry, including leading in-house counsel from branded and biosimilar companies, representatives from key government agencies, and the top patent and regulatory attorneys—will cover legal, regulatory, and commercial strategies for the innovator and biosimilars marketplace.
Webinar
|June 11, 2024
The SEC’s Spotlight on Digital Assets
Digital assets are transforming the financial services sector, but recent developments have increased the Securities and Exchange Commission’s interest and activity in the space. Many are left with questions such as:
Seminar/CLE
|June 4, 2024
2024 Health Care & Life Sciences Summit
Winston & Strawn is pleased to host our Annual Health Care & Life Sciences Summit on Tuesday, June 4, 2024, both virtually and in person in our Chicago office.
Other Results 91 results
Law Glossary
Where Is a List of Biosimilar Drugs and Biologics That Have Been Approved in the U.S.?
The FDA maintains a list of biosimilar drugs that have been approved in the USA. This list can be found here.
Law Glossary
What Is the Patent Trial and Appeal Board?
The Patent Trial and Appeal Board (PTAB) is a tribunal within U.S. Patent and Trademark Office. The PTAB oversees trial proceedings, namely: inter partes review (IPR), post-grant review (PGR), covered business method (CBM) review, and derivation proceedings. The Board also hears appeals from adverse patentability decisions by patent examiners in original applications, reissues, and reexaminations. And, while phasing out since the passage of the America Invents Act (AIA) in 2011, the PTAB is also responsible for deciding interferences. The PTAB was previously referred to as the Board of Patent Appeals and Interferences and was renamed by the AIA.
Site Content
A federal contract is a binding contract or agreement with an authorized official of any agency or department of the U.S. Government for the purpose of purchasing goods, products or services of any kind, or purchasing, renting, or leasing property, for the direct use or benefit of the U.S. Government. Federal contracts are the procurement mechanism the U.S. Government uses to obtain such goods, products, services, and property across all sectors and industries. Federal contracts may be express or implied and may be of various different types, e.g., fixed-price, cost-reimbursement, time and materials, indefinite delivery/indefinite quantity (IDIQ).